HCWB: HCWB to do 1-for-6 reverse split effective June 30 to meet Nasdaq $1 bid rule

AI Summary

HCW Biologics (HCWB) will effect a 1-for-6 reverse stock split at 12:01 a.m. ET on June 30, 2026, reducing shares outstanding from ~9.58M to ~1.60M (new CUSIP 40423R303) and will continue trading under the HCWB symbol on Nasdaq. The split is intended to ensure compliance with Nasdaq’s $1 minimum bid-price rule and conditions set by a Nasdaq Hearings Panel (the company completed at least 20 trading days above $1 and reported 28 consecutive days above $1), and the company warns failure to maintain the bid will risk immediate delisting; no fractional shares will be issued—holders otherwise due fractions will receive one whole share.

Positives

Company reported 28 consecutive trading days above $1 as of June 25, 2026
Reverse split is designed to satisfy Nasdaq Hearings Panel conditions and the $1 minimum bid rule, avoiding immediate delisting risk
Trades will continue under the existing HCWB ticker and transfer agent Equiniti will handle the exchange

Negatives

Company was out of compliance with Nasdaq’s minimum bid-price rule and required Panel relief
Must maintain share price above $1 per Panel conditions or face immediate delisting
Reverse split may reduce liquidity and can be viewed negatively by investors